REMSDESIVIR Tests Stopped Due To Side Effects: Kidney Failure
Dr. Mercola July 24, 2020
In the latest Remdesivir trial, four of the five patients developed major side effects, including kidney failure.
The NIH has brought together a panel of experts to make treatment recommendations, eight of whom have accepted research support or consulting fees from Gilead, the manufacturer of Remdesivir.
Research data have not supported the use of Remdesivir, which the company has priced at $3,100 for a course of treatment.
(Anon had read that it costs $9 to manufacture)